Report : Perfusion Systems Market to 2027- Global Analysis and Forecasts by Type (Microfluidic Perfusion Systems, Small-Mammal Organ Perfusion Systems, Bioreactor Perfusion Systems, gravity or Pressure-Driven Perfusion Systems); Component (Perfusion Pumps, Oxygenators, Herat-Lung Machines, Monitoring Systems, Cannulas and Others) and Geography
Bioreactor perfusion systems segment is expected to drive the growth of the global perfusion systems market by application
According to a new market research study titled ‘Perfusion Systems Market - Global Analysis and Forecasts by Type, and Component. The global perfusion systems market is expected to reach US$ 1,442.28 Mn in 2027 from US$ 1,044.75 Mn in 2018. The market is estimated to grow with a CAGR of 3.8% from 2019-2027. The report highlights the trends prevalent in the global perfusion systems market and the factors driving the market along with those that act as deterrents to its growth. The market is expected to grow due to the rising prevalence of cardiovascular diseases, significant growth of pharmaceutical and biotechnology industries, rising need for the organ transplantation, and rising cell based research activities. However, expensive organ transplant surgeries, and limited numbers of donors for organ transplant surgeries are likely to pose a negative impact on the market growth.
Global perfusion systems market, based on the component was segmented into oxygenators, heart-lung machine, perfusion pumps, monitoring systems, cannulas, and others. In 2018, the oxygenators segment held a largest market share of 33.1% of the perfusion systems market, by component. This segment is also expected to dominate the market in 2027 owing to the increasing number of the cardiovascular surgeries, liver transplantation and kidney transplantation worldwide. Moreover, the heart-lung machine segment is anticipated to witness the significant growth rate of 3.3% during the forecast period, 2019 to 2027 owing to the incidences of the coronary heart diseases.
Some of the prominent players operating in perfusion systems market are REPLIGEN CORPORATION, Merck KGaA, Ala Scientific Instruments, Inc., XVIVO Perfusion, Medtronic, XENIOS AG (Fresenius Medical Care AG & Co. KGaA), Getinge AB, TERUMO CORPORATION, LivaNova PLC, Sartorius AG, Harvard Bioscience, RAND, Sanisure (Sani-Tech West, Inc.), AutoMate Scientific, Inc., Jobst Technologies GmbH, APD (Advanced Perfusion Diagnostics), Spectrum Medical, Transonic Systems Inc, OrganOx, ISCHEMAVIEW, INC, and CESCO BIOENGINEERING CO., LTD. The market players are focused towards bringing new and innovative products through inorganic activities to sustain their position in the market. For instance, in June, 2018, XVIVO Perfusion, Inc. and United Therapeutics Corporation signed a collaboration to use the XVIVO’s ex-vivo lung perfusion (EVLP) technology in the Silver Spring, Maryland laboratory of Lung Bioengineering Inc.
The report segments the global perfusion systems market as follows:
Global Perfusion Systems Market – By Type
Global Perfusion Systems Market – By Component
Global Perfusion Systems Market – By Geography
Contact Person: Sameer Joshi
Email Id: email@example.com